Michael Scouvart
About Michael Scouvart
Michael Scouvart serves as the Chief Commercial Officer at QuVa Pharma, Inc. He has extensive experience in marketing and commercial roles within the pharmaceutical industry, having held positions at Mylan and Pfizer over a career spanning more than two decades.
Current Role at QuVa Pharma
Michael Scouvart serves as the Chief Commercial Officer (CCO) at QuVa Pharma, Inc. since 2022. In this role, he oversees commercial strategies and initiatives to enhance the company's market presence. His leadership is focused on driving growth and ensuring the effective delivery of pharmaceutical solutions.
Previous Experience at QuVa Pharma
Prior to his current position, Scouvart held several roles at QuVa Pharma, Inc. He was the Vice President of Marketing & Corporate Communications from 2020 to 2022, where he managed marketing strategies and corporate messaging. Additionally, he served as Vice President of Sales and Marketing from 2017 to 2019, contributing to the company's sales strategies and marketing efforts.
Career at Mylan
Michael Scouvart worked at Mylan in various capacities. He was the Head of the Health Solutions Business Unit for 9 months in 2017. Prior to that, he served as Vice President of Marketing for Mylan Pharmaceuticals & Mylan Institutional from 2014 to 2015. He also held the position of Vice President, Head of Marketing for North America from 2015 to 2017, where he directed marketing operations across the region.
Experience at Pfizer
Scouvart's career includes significant experience at Pfizer. He worked as Marketing Director at Pfizer Oncology from 2009 to 2012, focusing on oncology product marketing. He also held the role of Regional Operations Manager in the Greater Chicago Area for 6 months in 2002, followed by a 6-year tenure as Area Sales Manager for Pfizer Specialty & Oncology from 2003 to 2009.
Educational Background
Michael Scouvart earned his Master of Business Administration (MBA) from The Ohio State University Fisher College of Business, completing his studies from 2001 to 2003. He also holds a Bachelor of Science in Biology from California University of Pennsylvania, where he developed a foundational understanding of the life sciences.